Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Influenza

Free Subscription Articles published in Cell Retrieve available abstracts of 129 articles: HTML format

Single Articles

April 2021
1. LEBLANC EV, Colpitts CC
   SARS-CoV-2 RNA: Exclusive friends and common foes.
   Cell. 2021;184:2276-2278.
   PubMed     Abstract available
   
   
   
2. BOEHM JS
   The power of parent scientists.
   Cell. 2021;184:2263-2270.
   PubMed     Abstract available
   
   
   
3. HOFFMANN M, Arora P, Gross R, Seidel A, et al
   SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
   Cell. 2021;184:2384-2393.
   PubMed     Abstract available
   
   
   
4. SURYADEVARA N, Shrihari S, Gilchuk P, VanBlargan LA, et al
   Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.
   Cell. 2021;184:2316-2331.
   PubMed     Abstract available
   
   
   
5. FABIUS JM, Krogan NJ
   Creating collaboration by breaking down scientific barriers.
   Cell. 2021;184:2271-2275.
   PubMed     Abstract available
   
   
   
6. MCCALLUM M, De Marco A, Lempp FA, Tortorici MA, et al
   N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
   Cell. 2021;184:2332-2347.
   PubMed     Abstract available
   
   
   
7. GARCIA-BELTRAN WF, Lam EC, St Denis K, Nitido AD, et al
   Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
   Cell. 2021;184:2372-2383.
   PubMed     Abstract available
   
   
   
8. FLYNN RA, Belk JA, Qi Y, Yasumoto Y, et al
   Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions.
   Cell. 2021;184:2394-2411.
   PubMed     Abstract available
   
   
   
9. ZHOU D, Dejnirattisai W, Supasa P, Liu C, et al
   Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.
   Cell. 2021;184:2348-2361.
   PubMed     Abstract available
   
   
   
10. 
    The origins of viral infection sleuth.
    Cell. 2021;184:1960-1961.
    PubMed     Abstract available
    
    
    
11. SCHNEIDER JL, Rowe JH, Garcia-de-Alba C, Kim CF, et al
    The aging lung: Physiology, disease, and immunity.
    Cell. 2021;184:1990-2019.
    PubMed     Abstract available
    
    
    
12. MILLS RJ, Humphrey SJ, Fortuna PRJ, Lor M, et al
    BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.
    Cell. 2021;184:2167-2182.
    PubMed     Abstract available
    
    
    
13. DEJNIRATTISAI W, Zhou D, Ginn HM, Duyvesteyn HME, et al
    The antigenic anatomy of SARS-CoV-2 receptor binding domain.
    Cell. 2021;184:2183-2200.
    PubMed     Abstract available
    
    
    
14. SUPASA P, Zhou D, Dejnirattisai W, Liu C, et al
    Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.
    Cell. 2021;184:2201-2211.
    PubMed     Abstract available
    
    
    
15. YEUNG ML, Teng JLL, Jia L, Zhang C, et al
    Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system.
    Cell. 2021;184:2212-2228.
    PubMed     Abstract available
    
    
    
16. ZHANG X, Liu Y, Liu J, Bailey AL, et al
    A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.
    Cell. 2021;184:2229-2238.
    PubMed     Abstract available
    
    
    
17. SCHULTZE JL, Aschenbrenner AC
    COVID-19 and the human innate immune system.
    Cell. 2021;184:1671-1692.
    PubMed     Abstract available
    
    
    
18. YU B, Qi Y, Li R, Shi Q, et al
    B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells.
    Cell. 2021;184:1790-1803.
    PubMed     Abstract available
    
    
    
19. LIU C, Martins AJ, Lau WW, Rachmaninoff N, et al
    Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.
    Cell. 2021;184:1836-1857.
    PubMed     Abstract available
    
    
    
20. WINKLER ES, Gilchuk P, Yu J, Bailey AL, et al
    Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.
    Cell. 2021;184:1804-1820.
    PubMed     Abstract available
    
    
    
21. ANDREANO E, Nicastri E, Paciello I, Pileri P, et al
    Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
    Cell. 2021;184:1821-1835.
    PubMed     Abstract available
    
    
    
22. REN X, Wen W, Fan X, Hou W, et al
    COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
    Cell. 2021;184:1895-1913.
    PubMed     Abstract available
    
    
    
23. SUN L, Li P, Ju X, Rao J, et al
    In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.
    Cell. 2021;184:1865-1883.
    PubMed     Abstract available
    
    
    
24. ANDERSON EM, Goodwin EC, Verma A, Arevalo CP, et al
    Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.
    Cell. 2021;184:1858-1864.
    PubMed     Abstract available
    
    
    March 2021
25. GEBRE MS, Brito LA, Tostanoski LH, Edwards DK, et al
    Novel approaches for vaccine development.
    Cell. 2021;184:1589-1603.
    PubMed     Abstract available
    
    
    
26. SANDRONE S, Scott G, Anderson WJ, Musunuru K, et al
    Active learning-based STEM education for in-person and online learning.
    Cell. 2021;184:1409-1414.
    PubMed     Abstract available
    
    
    
27. 
    Scientific misinformation: A perfect storm, missteps, and moving forward.
    Cell. 2021;184:1402-1406.
    PubMed     Abstract available
    
    
    
28. TOPOL EJ
    Messenger RNA vaccines against SARS-CoV-2.
    Cell. 2021;184:1401.
    PubMed     Abstract available
    
    
    
29. PILLON NJ, Loos RJF, Marshall SM, Zierath JR, et al
    Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care.
    Cell. 2021;184:1530-1544.
    PubMed     Abstract available
    
    
    
30. THOMSON EC, Rosen LE, Shepherd JG, Spreafico R, et al
    Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.
    Cell. 2021;184:1171-1187.
    PubMed     Abstract available
    
    
    
31. GRUBAUGH ND, Hodcroft EB, Fauver JR, Phelan AL, et al
    Public health actions to control new SARS-CoV-2 variants.
    Cell. 2021;184:1127-1132.
    PubMed     Abstract available
    
    
    
32. BROUWER PJM, Brinkkemper M, Maisonnasse P, Dereuddre-Bosquet N, et al
    Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection.
    Cell. 2021;184:1188-1200.
    PubMed     Abstract available
    
    
    
33. SOKAL A, Chappert P, Barba-Spaeth G, Roeser A, et al
    Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
    Cell. 2021;184:1201-1213.
    PubMed     Abstract available
    
    
    February 2021
34. LI Q, Nie J, Wu J, Zhang L, et al
    SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.
    Cell. 2021 Feb 23. pii: S0092-8674(21)00231-2. doi: 10.1016/j.cell.2021.
    PubMed     Abstract available
    
    
    
35. SETTE A, Crotty S
    Adaptive immunity to SARS-CoV-2 and COVID-19.
    Cell. 2021;184:861-880.
    PubMed     Abstract available
    
    
    
36. NIE X, Qian L, Sun R, Huang B, et al
    Multi-organ proteomic landscape of COVID-19 autopsies.
    Cell. 2021;184:775-791.
    PubMed     Abstract available
    
    
    
37. ATYEO C, Pullen KM, Bordt EA, Fischinger S, et al
    Compromised SARS-CoV-2-specific placental antibody transfer.
    Cell. 2021;184:628-642.
    PubMed     Abstract available
    
    
    January 2021
38. GARCIA-BELTRAN WF, Lam EC, Astudillo MG, Yang D, et al
    COVID-19-neutralizing antibodies predict disease severity and survival.
    Cell. 2021;184:476-488.
    PubMed     Abstract available
    
    
    
39. HOANG TN, Pino M, Boddapati AK, Viox EG, et al
    Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.
    Cell. 2021;184:460-475.
    PubMed     Abstract available
    
    
    
40. HOFFMANN HH, Schneider WM, Rozen-Gagnon K, Miles LA, et al
    TMEM41B Is a Pan-flavivirus Host Factor.
    Cell. 2021;184:133-148.
    PubMed     Abstract available
    
    
    
41. WANG R, Simoneau CR, Kulsuptrakul J, Bouhaddou M, et al
    Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.
    Cell. 2021;184:106-119.
    PubMed     Abstract available
    
    
    
42. RODDA LB, Netland J, Shehata L, Pruner KB, et al
    Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.
    Cell. 2021;184:169-183.
    PubMed     Abstract available
    
    
    
43. KARKI R, Sharma BR, Tuladhar S, Williams EP, et al
    Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
    Cell. 2021;184:149-168.
    PubMed     Abstract available
    
    
    
44. VOLZ E, Hill V, McCrone JT, Price A, et al
    Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.
    Cell. 2021;184:64-75.
    PubMed     Abstract available
    
    
    
45. DANILOSKI Z, Jordan TX, Wessels HH, Hoagland DA, et al
    Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.
    Cell. 2021;184:92-105.
    PubMed     Abstract available
    
    
    
46. WEI J, Alfajaro MM, DeWeirdt PC, Hanna RE, et al
    Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
    Cell. 2021;184:76-91.
    PubMed     Abstract available
    
    
    December 2020
47. AVANZATO VA, Matson MJ, Seifert SN, Pryce R, et al
    Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.
    Cell. 2020;183:1901-1912.
    PubMed     Abstract available
    
    
    
48. ZOHAR T, Loos C, Fischinger S, Atyeo C, et al
    Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.
    Cell. 2020;183:1508-1519.
    PubMed     Abstract available
    
    
    
49. SU Y, Chen D, Yuan D, Lausted C, et al
    Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
    Cell. 2020;183:1479-1495.
    PubMed     Abstract available
    
    
    
50. CHEN Y, Zuiani A, Fischinger S, Mullur J, et al
    Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.
    Cell. 2020;183:1496-1507.
    PubMed     Abstract available
    
    
    
51. GHOSH S, Dellibovi-Ragheb TA, Kerviel A, Pak E, et al
    beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway.
    Cell. 2020;183:1520-1535.
    PubMed     Abstract available
    
    
    November 2020
52. WALLS AC, Fiala B, Schafer A, Wrenn S, et al
    Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
    Cell. 2020;183:1367-1382.
    PubMed     Abstract available
    
    
    
53. MECKIFF BJ, Ramirez-Suastegui C, Fajardo V, Chee SJ, et al
    Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19.
    Cell. 2020;183:1340-1353.
    PubMed     Abstract available
    
    
    
54. BANERJEE AK, Blanco MR, Bruce EA, Honson DD, et al
    SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
    Cell. 2020;183:1325-1339.
    PubMed     Abstract available
    
    
    
55. AID M, Busman-Sahay K, Vidal SJ, Maliga Z, et al
    Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques.
    Cell. 2020;183:1354-1366.
    PubMed     Abstract available
    
    
    
56. KREYE J, Reincke SM, Kornau HC, Sanchez-Sendin E, et al
    A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.
    Cell. 2020;183:1058-1069.
    PubMed     Abstract available
    
    
    
57. LEIST SR, Dinnon KH 3rd, Schafer A, Tse LV, et al
    A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.
    Cell. 2020;183:1070-1085.
    PubMed     Abstract available
    
    
    
58. RYDYZNSKI MODERBACHER C, Ramirez SI, Dan JM, Grifoni A, et al
    Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
    Cell. 2020;183:996-1012.
    PubMed     Abstract available
    
    
    
59. PICCOLI L, Park YJ, Tortorici MA, Czudnochowski N, et al
    Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
    Cell. 2020;183:1024-1042.
    PubMed     Abstract available
    
    
    
60. GRUBER CN, Patel RS, Trachtman R, Lepow L, et al
    Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).
    Cell. 2020;183:982-995.
    PubMed     Abstract available
    
    
    
61. CLAUSEN TM, Sandoval DR, Spliid CB, Pihl J, et al
    SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
    Cell. 2020;183:1043-1057.
    PubMed     Abstract available
    
    
    
62. CONSIGLIO CR, Cotugno N, Sardh F, Pou C, et al
    The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.
    Cell. 2020;183:968-981.
    PubMed     Abstract available
    
    
    October 2020
63. YURKOVETSKIY L, Wang X, Pascal KE, Tomkins-Tinch C, et al
    Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
    Cell. 2020;183:739-751.
    PubMed     Abstract available
    
    
    
64. MUKHERJEE S
    Before Virus, After Virus: A Reckoning.
    Cell. 2020;183:308-314.
    PubMed     Abstract available
    
    
    
65. IWASAKI A, Omer SB
    Why and How Vaccines Work.
    Cell. 2020;183:290-295.
    PubMed     Abstract available
    
    
    
66. GOLDSTEIN JL
    The Spanish 1918 Flu and the COVID-19 Disease: The Art of Remembering and Foreshadowing Pandemics.
    Cell. 2020;183:285-289.
    PubMed     Abstract available
    
    
    
67. LI W, Schafer A, Kulkarni SS, Liu X, et al
    High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models.
    Cell. 2020;183:429-441.
    PubMed     Abstract available
    
    
    
68. SEKINE T, Perez-Potti A, Rivera-Ballesteros O, Stralin K, et al
    Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
    Cell. 2020;183:158-168.
    PubMed     Abstract available
    
    
    
69. AU L, Boos LA, Swerdlow A, Byrne F, et al
    Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study.
    Cell. 2020;183:4-10.
    PubMed     Abstract available
    
    
    
70. CANETE PF, Vinuesa CG
    COVID-19 Makes B Cells Forget, but T Cells Remember.
    Cell. 2020;183:13-15.
    PubMed     Abstract available
    
    
    
71. HASSAN AO, Kafai NM, Dmitriev IP, Fox JM, et al
    A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
    Cell. 2020;183:169-184.
    PubMed     Abstract available
    
    
    
72. IADECOLA C, Anrather J, Kamel H
    Effects of COVID-19 on the Nervous System.
    Cell. 2020;183:16-27.
    PubMed     Abstract available
    
    
    
73. KANEKO N, Kuo HH, Boucau J, Farmer JR, et al
    Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.
    Cell. 2020;183:143-157.
    PubMed     Abstract available
    
    
    September 2020
74. SILVIN A, Chapuis N, Dunsmore G, Goubet AG, et al
    Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
    Cell. 2020;182:1401-1418.
    PubMed     Abstract available
    
    
    
75. COLUBRI A, Kemball M, Sani K, Boehm C, et al
    Preventing Outbreaks through Interactive, Experiential Real-Life Simulations.
    Cell. 2020;182:1366-1371.
    PubMed     Abstract available
    
    
    
76. SCHULTE-SCHREPPING J, Reusch N, Paclik D, Bassler K, et al
    Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
    Cell. 2020;182:1419-1440.
    PubMed     Abstract available
    
    
    
77. DU S, Cao Y, Zhu Q, Yu P, et al
    Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy.
    Cell. 2020 Sep 14. pii: S0092-8674(20)31232-0. doi: 10.1016/j.cell.2020.
    PubMed     Abstract available
    
    
    
78. MORENS DM, Fauci AS
    Emerging Pandemic Diseases: How We Got to COVID-19.
    Cell. 2020;182:1077-1092.
    PubMed     Abstract available
    
    
    August 2020
79. GRUBAUGH ND, Hanage WP, Rasmussen AL
    Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.
    Cell. 2020;182:794-795.
    PubMed     Abstract available
    
    
    
80. KORBER B, Fischer WM, Gnanakaran S, Yoon H, et al
    Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
    Cell. 2020;182:812-827.
    PubMed     Abstract available
    
    
    
81. KREER C, Zehner M, Weber T, Ercanoglu MS, et al
    Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
    Cell. 2020;182:843-854.
    PubMed     Abstract available
    
    
    
82. BARNES CO, West AP Jr, Huey-Tubman KE, Hoffmann MAG, et al
    Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.
    Cell. 2020;182:828-842.
    PubMed     Abstract available
    
    
    
83. GEITMANN A
    Travel Less. Make It Worthwhile.
    Cell. 2020;182:790-793.
    PubMed     Abstract available
    
    
    
84. WANG H, Zhang Y, Huang B, Deng W, et al
    Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.
    Cell. 2020;182:713-721.
    PubMed     Abstract available
    
    
    
85. DAI L, Zheng T, Xu K, Han Y, et al
    A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS.
    Cell. 2020;182:722-733.
    PubMed     Abstract available
    
    
    
86. BOUHADDOU M, Memon D, Meyer B, White KM, et al
    The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
    Cell. 2020;182:685-712.
    PubMed     Abstract available
    
    
    
87. SUN J, Zhuang Z, Zheng J, Li K, et al
    Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
    Cell. 2020;182:734-743.
    PubMed     Abstract available
    
    
    
88. HASSAN AO, Case JB, Winkler ES, Thackray LB, et al
    A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.
    Cell. 2020;182:744-753.
    PubMed     Abstract available
    
    
    July 2020
89. EINAV T, Gentles LE, Bloom JD
    SnapShot: Influenza by the Numbers.
    Cell. 2020;182:532-532.
    PubMed     Abstract available
    
    
    
90. JIANG RD, Liu MQ, Chen Y, Shan C, et al
    Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.
    Cell. 2020;182:50-58.
    PubMed     Abstract available
    
    
    
91. SHEN B, Yi X, Sun Y, Bi X, et al
    Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.
    Cell. 2020;182:59-72.
    PubMed     Abstract available
    
    
    
92. CAO Y, Su B, Guo X, Sun W, et al
    Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.
    Cell. 2020;182:73-84.
    PubMed     Abstract available
    
    
    
93. JOYCE MG, Wheatley AK, Modjarrad K
    Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.
    Cell. 2020;182:7-9.
    PubMed     Abstract available
    
    
    June 2020
94. SEMPOWSKI GD, Saunders KO, Acharya P, Wiehe KJ, et al
    Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19.
    Cell. 2020;181:1458-1463.
    PubMed     Abstract available
    
    
    
95. BOST P, Giladi A, Liu Y, Bendjelal Y, et al
    Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.
    Cell. 2020;181:1475-1488.
    PubMed     Abstract available
    
    
    
96. GRIFONI A, Weiskopf D, Ramirez SI, Mateus J, et al
    Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
    Cell. 2020;181:1489-1501.
    PubMed     Abstract available
    
    
    
97. ZEGGINI E, Baumann M, Gotz M, Herzig S, et al
    Biomedical Research Goes Viral: Dangers and Opportunities.
    Cell. 2020;181:1189-1193.
    PubMed     Abstract available
    
    
    
98. ZHANG K, Liu X, Shen J, Li Z, et al
    Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography.
    Cell. 2020;181:1423-1433.
    PubMed     Abstract available
    
    
    
99. CASANOVA JL, Su HC
    A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.
    Cell. 2020;181:1194-1199.
    PubMed     Abstract available
    
    
    May 2020
100. NETEA MG, Giamarellos-Bourboulis EJ, Dominguez-Andres J, Curtis N, et al
     Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.
     Cell. 2020;181:969-977.
     PubMed     Abstract available
     
     
     
101. BLANCO-MELO D, Nilsson-Payant BE, Liu WC, Uhl S, et al
     Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
     Cell. 2020;181:1036-1045.
     PubMed     Abstract available
     
     
     
102. ZIEGLER CGK, Allon SJ, Nyquist SK, Mbano IM, et al
     SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
     Cell. 2020;181:1016-1035.
     PubMed     Abstract available
     
     
     
103. FAUVER JR, Petrone ME, Hodcroft EB, Shioda K, et al
     Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States.
     Cell. 2020;181:990-996.
     PubMed     Abstract available
     
     
     
104. WRAPP D, De Vlieger D, Corbett KS, Torres GM, et al
     Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.
     Cell. 2020;181:1004-1015.
     PubMed     Abstract available
     
     
     
105. LU J, du Plessis L, Liu Z, Hill V, et al
     Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China.
     Cell. 2020;181:997-1003.
     PubMed     Abstract available
     
     
     
106. HOU YJ, Okuda K, Edwards CE, Martinez DR, et al
     SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
     Cell. 2020 May 27. pii: S0092-8674(20)30675-9. doi: 10.1016/j.cell.2020.
     PubMed     Abstract available
     
     
     
107. OBERFELD B, Achanta A, Carpenter K, Chen P, et al
     SnapShot: COVID-19.
     Cell. 2020;181:954-954.
     PubMed     Abstract available
     
     
     
108. MONTEIL V, Kwon H, Prado P, Hagelkruys A, et al
     Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.
     Cell. 2020;181:905-913.
     PubMed     Abstract available
     
     
     April 2020
109. ABBOTT TR, Dhamdhere G, Liu Y, Lin X, et al
     Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.
     Cell. 2020 Apr 29. pii: S0092-8674(20)30483-9. doi: 10.1016/j.cell.2020.
     PubMed     Abstract available
     
     
     
110. WANDZIK JM, Kouba T, Karuppasamy M, Pflug A, et al
     A Structure-Based Model for the Complete Transcription Cycle of Influenza Polymerase.
     Cell. 2020 Apr 16. pii: S0092-8674(20)30389-5. doi: 10.1016/j.cell.2020.
     PubMed     Abstract available
     
     
     
111. 
     COVID-19: Navigating Uncertainties Together.
     Cell. 2020;181:209-210.
     PubMed    
     
     
     
112. ZHANG YZ, Holmes EC
     A Genomic Perspective on the Origin and Emergence of SARS-CoV-2.
     Cell. 2020;181:223-227.
     PubMed     Abstract available
     
     
     
113. HOFFMANN M, Kleine-Weber H, Schroeder S, Kruger N, et al
     SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
     Cell. 2020;181:271-280.
     PubMed     Abstract available
     
     
     March 2020
114. ZHANG T, Yin C, Boyd DF, Quarato G, et al
     Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis.
     Cell. 2020;180:1115-1129.
     PubMed     Abstract available
     
     
     
115. 
     The Novel Coronavirus Outbreak: What We Know and What We Don't.
     Cell. 2020;180:1034-1036.
     PubMed    
     
     
     January 2020
116. VAHEY MD, Fletcher DA
     Low-Fidelity Assembly of Influenza A Virus Promotes Escape from Host Cells.
     Cell. 2020;180:205.
     PubMed    
     
     
     May 2019
117. GARCIA-SASTRE A
     Snatch-and-Grab Inhibitors to Fight the Flu.
     Cell. 2019;177:1367.
     PubMed     Abstract available
     
     
     
118. BANGARU S, Lang S, Schotsaert M, Vanderven HA, et al
     A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface.
     Cell. 2019;177:1136-1152.
     PubMed     Abstract available
     
     
     
119. WATANABE A, McCarthy KR, Kuraoka M, Schmidt AG, et al
     Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism.
     Cell. 2019;177:1124-1135.
     PubMed     Abstract available
     
     
     
120. WU Y, Gao GF
     "Breathing" Hemagglutinin Reveals Cryptic Epitopes for Universal Influenza Vaccine Design.
     Cell. 2019;177:1086-1088.
     PubMed     Abstract available
     
     
     January 2019
121. VAHEY MD, Fletcher DA
     Low-Fidelity Assembly of Influenza A Virus Promotes Escape from Host Cells.
     Cell. 2019;176:678.
     PubMed    
     
     
     
122. MARTIN BE, Brooke CB
     Flu Shows the Power of Diversity.
     Cell. 2019;176.
     PubMed     Abstract available
     
     
     November 2018
123. VAHEY MD, Fletcher DA
     Low-Fidelity Assembly of Influenza A Virus Promotes Escape from Host Cells.
     Cell. 2018 Nov 27. pii: S0092-8674(18)31455-7. doi: 10.1016/j.cell.2018.
     PubMed     Abstract available
     
     
     June 2018
124. DAS DK, Govindan R, Nikic-Spiegel I, Krammer F, et al
     Direct Visualization of the Conformational Dynamics of Single Influenza Hemagglutinin Trimers.
     Cell. 2018 Jun 21. pii: S0092-8674(18)30713-X. doi: 10.1016/j.cell.2018.
     PubMed     Abstract available
     
     
     April 2018
125. CHEN YQ, Wohlbold TJ, Zheng NY, Huang M, et al
     Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.
     Cell. 2018;173:417-429.
     PubMed     Abstract available
     
     
     March 2018
126. GAO GF
     From "A"IV to "Z"IKV: Attacks from Emerging and Re-emerging Pathogens.
     Cell. 2018;172:1157-1159.
     PubMed     Abstract available
     
     
     January 2018
127. GAYA M, Barral P, Burbage M, Aggarwal S, et al
     Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells.
     Cell. 2018;172:517-533.
     PubMed     Abstract available
     
     
     May 2017
128. RIALDI A, Hultquist J, Jimenez-Morales D, Peralta Z, et al
     The RNA Exosome Syncs IAV-RNAPII Transcription to Promote Viral Ribogenesis and Infectivity.
     Cell. 2017;169:679-692.
     PubMed     Abstract available
     
     
     September 2016
129. WANG A, Huen SC, Luan HH, Yu S, et al
     Opposing Effects of Fasting Metabolism on Tissue Tolerance in Bacterial and Viral Inflammation.
     Cell. 2016;166:1512-1525.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: